Sources Lisdexamfetamine Dimesylate (Vyvanse), A Prodrug Stimulant for Attention-Deficit/Hyperactivity Disorder
Given the potential benefits of therapeutic nutritional ketosis and the restoration of metabolic health (44), there is a pressing need to identify the biological underpinnings of KD in psychiatric disorders and delineate factors associated with the successful adoption and adherence of KMT and responses in common psychiatric disorders such as depression and anxiety
At any time, you are able to unsubscribe from these messages
It also drives the patent thicket and secondary patent strategies that create the apparent gap between the nominal patent term and actual generic entry
Research focus How Reconstitution BAC is studied Summary of contexts in which this compound appears in the preclinical literature
Ertugliflozin (brand name Steglatro) : Approved in 2017, this is an SGLT2 inhibitor that, apart from lowering blood sugar levels, has been evaluated for its cardiovascular benefits